This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Bayer Intellectual Property Gmbh. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Andreas Strub in Fused Pyrimidines
Introduction
Andreas Strub, an inventor based in Planegg, Germany, has made significant contributions to the field of pharmaceuticals through his work on fused pyrimidines. With a focus on novel compounds, his research aims to enhance the efficacy of therapeutic agents.
Latest Patents
Andreas Strub holds one patent related to fused pyrimidines, specifically for compounds of formula (I). This innovation contributes to the expanding reservoir of pharmaceutical compounds that can potentially lead to advancements in drug development.
Career Highlights
Strub's career is closely tied to Bayer Intellectual Property GmbH, where he applies his expertise in chemical compounds and their applications. His work involves the synthesis and testing of novel substances to improve therapeutic outcomes.
Collaborations
Throughout his career, Strub has collaborated with esteemed colleagues such as Matthias Vennemann and Thomas Bär. These partnerships foster a collaborative research environment that drives innovation and the exploration of new chemical entities.
Conclusion
Andreas Strub's contributions through his patent on fused pyrimidines exemplify the continuous effort to push the boundaries of pharmaceutical science. His work at Bayer Intellectual Property GmbH underscores the importance of collaboration among inventors to achieve groundbreaking advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile